Accelerate to Offer Shares, Raising $20M | GenomeWeb

NEW YORK (GenomeWeb News) – Accelerate Diagnostics has filed a regulatory document with the US Securities and Exchange Commission for a rights offering to existing shareholders to raise about $20 million in gross proceeds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.